2020
DOI: 10.1002/jmv.25783
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: The outbreak of the novel coronavirus in China (SARS-CoV-2) that began in December 2019 presents a significant and urgent threat to global health. This study was conducted to provide the international community with a deeper understanding of this new infectious disease. Epidemiological, clinical features, laboratory findings, radiological characteristics, treatment, and clinical outcomes of 135 patients in northeast Chongqing were collected and analyzed in this study. A total of 135 hospitalized patients with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

36
835
7
46

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 829 publications
(924 citation statements)
references
References 20 publications
36
835
7
46
Order By: Relevance
“…30 studies were included in the qualitative synthesis and meta-analysis [ Figure 1]. [3,8,[17][18][19][20][21][22][23][24][25][26]9,[27][28][29][30][31][32][33][34][35][36][10][11][12][13][14][15][16] There were a total of 6452 patients from 30 studies.…”
Section: Study Selection and Characteristicsmentioning
confidence: 99%
“…30 studies were included in the qualitative synthesis and meta-analysis [ Figure 1]. [3,8,[17][18][19][20][21][22][23][24][25][26]9,[27][28][29][30][31][32][33][34][35][36][10][11][12][13][14][15][16] There were a total of 6452 patients from 30 studies.…”
Section: Study Selection and Characteristicsmentioning
confidence: 99%
“…The clinical efficacy of corticosteroids in treating COVID-19 is currently unclear, with some groups advising against their use (Russell et al, 2020). However, retrospective studies suggest corticosteroids are not uncommonly used to treat hospitalized COVID-19 patients Mo et al, 2020;Wan et al, 2020). Similarly, high doses of corticosteroids were administered to treat SARS CoV-1 infection symptoms during the acute phase (Lee et al, 2003), but were associated with organic hallucinations and manic symptoms, which were treated with haloperidol (Cheng et al, 2004).…”
Section: Immunomodulatory Treatmentsmentioning
confidence: 99%
“…The included publications needed to be in English language and include COVID-19 patients diagnosed with RT-PCR and reporting CT findings and performances. Case reports, commentary and review were excluded, as well as studies on pediatric populations and pregnant women, leaving N=22 studies [9][10][11][12][13][14][15][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35] (Table 1). The included studies had fair and good quality scores according to "The NIH Quality Assessment Tool for Case Series Studies" 36 , sharing clear study design and aims, comparable population, clear measurement of outcome and clear description and/or representation of results.…”
Section: Ct In Covid-19 Demonstrates High Ppv and Npv Values In Condimentioning
confidence: 99%